These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
124 related articles for article (PubMed ID: 32214765)
1. Synthesis, antitubercular and anticancer activity of new Baylis-Hillman adduct-derived Kumar SB; Ravinder M; Kishore G; Jayathirtha Rao V; Yogeeswari P; Sriram D Med Chem Res; 2014; 23(4):1934-1940. PubMed ID: 32214765 [TBL] [Abstract][Full Text] [Related]
2. Synthesis, Biological Evaluation and Molecular Docking Studies of New Pyrazolines as an Antitubercular and Cytotoxic Agents. Lokesh BVS; Prasad YR; Shaik AB Infect Disord Drug Targets; 2019; 19(3):310-321. PubMed ID: 30556506 [TBL] [Abstract][Full Text] [Related]
4. Synthesis, Cytotoxic Activity on Leukemia Cell Lines and Quantitative Structure-Activity Relationships (QSAR) Studies of Morita-Baylis-Hillman Adducts. Lima- CG; Faheina-Martins GV; Bomfim CC; Dantas BB; Silva EP; Araújo DA; Filho EB; Vasconcellos ML Med Chem; 2016; 12(7):602-612. PubMed ID: 27150963 [TBL] [Abstract][Full Text] [Related]
5. Synthesis of Substituted Isatins from the MBH Adduct of 1,5,6-Trisubstituted Isatins Using (2,4-Dinitrophenyl)hydrazine and K-10 Clay Explored as Protection-Deprotection Chemistry. Vadivel V; Ganesan R; Kannaiyan V; Vellikannu E; Vijayakumar T ACS Omega; 2019 May; 4(5):9563-9568. PubMed ID: 31460047 [TBL] [Abstract][Full Text] [Related]
6. Systematic Review on Cytotoxic and Anticancer Potential of N-Substituted Isatins as Novel Class of Compounds Useful in Multidrug-Resistant Cancer Therapy: In Silico and In Vitro Analysis. Gupta AK; Tulsyan S; Bharadwaj M; Mehrotra R Top Curr Chem (Cham); 2019 May; 377(3):15. PubMed ID: 31073777 [TBL] [Abstract][Full Text] [Related]
7. Molecular hybridization of bioactives: synthesis and antitubercular evaluation of novel dibenzofuran embodied homoisoflavonoids via Baylis-Hillman reaction. Yempala T; Sriram D; Yogeeswari P; Kantevari S Bioorg Med Chem Lett; 2012 Dec; 22(24):7426-30. PubMed ID: 23151429 [TBL] [Abstract][Full Text] [Related]
8. Enantioselective Morita-Baylis-Hillman reaction of isatins with acrylates: facile creation of 3-hydroxy-2-oxindoles. Zhong F; Chen GY; Lu Y Org Lett; 2011 Jan; 13(1):82-5. PubMed ID: 21138329 [TBL] [Abstract][Full Text] [Related]
9. Eco-friendly K-10 Clay-Mediated [3 + 3] Spiroannulation of Morita-Baylis-Hillman Adduct of Isatin with Anthracene: Synthesis of Green Fluorophore Compounds. Vaithiyanathan V; Sivaraman S ACS Omega; 2024 Jan; 9(1):934-941. PubMed ID: 38222519 [TBL] [Abstract][Full Text] [Related]
10. Highly enantioselective [3 + 2]-annulation of isatin-derived morita-baylis-hillman adducts with cyclic sulfonimines. Wei F; Huang HY; Zhong NJ; Gu CL; Wang D; Liu L Org Lett; 2015 Apr; 17(7):1688-91. PubMed ID: 25781216 [TBL] [Abstract][Full Text] [Related]
12. Molecular docking and synthesis of N-alkyl-isatin-3-imino aromatic amine derivatives and their antileishmanial and cytotoxic activities. Hassanzadeh F; Hejazi SH; Jafari E; Fard AM; Sadeghi-Aliabadi H Res Pharm Sci; 2024 Apr; 19(2):238-250. PubMed ID: 39035577 [TBL] [Abstract][Full Text] [Related]
13. [4 + 3] Cycloadditions with Bromo-Substituted Morita-Baylis-Hillman Adducts of Isatins and N-(ortho-Chloromethyl)aryl Amides. Zhan G; Shi ML; He Q; Du W; Chen YC Org Lett; 2015 Oct; 17(19):4750-3. PubMed ID: 26359687 [TBL] [Abstract][Full Text] [Related]
14. Lewis base effects in the Baylis-Hillman reaction of imines with cyclohex-2-en-1-one and cyclopent-2-en-1-one. Shi M; Xu YM Chem Commun (Camb); 2001 Sep; (18):1876-7. PubMed ID: 12240358 [TBL] [Abstract][Full Text] [Related]
15. Synthesis and Antibacterial Activity of Mefloquine-Based Analogs Against Sensitive and Resistant Mycobacterium tuberculosis Strains. da Silva Araújo A; Moraes AM; Lourenço MCS; Pessoa CO; da Silva ET; de Souza MVN Curr Top Med Chem; 2019; 19(9):683-689. PubMed ID: 30836914 [TBL] [Abstract][Full Text] [Related]
16. Indole-based hydrazide-hydrazones and 4-thiazolidinones: synthesis and evaluation as antitubercular and anticancer agents. Cihan-Üstündağ G; Şatana D; Özhan G; Çapan G J Enzyme Inhib Med Chem; 2016; 31(3):369-80. PubMed ID: 25910087 [TBL] [Abstract][Full Text] [Related]